May 23, 2018
##EMAIL##, you've received this email because you're a
valued customer of IsoTech Design.

##EMAIL##, vous recevez ce courriel parce ce que vous êtes un précieux client d'IsoTech Design.
Home   About Us   News & Articles   Contact Us   Text Version   Subscribe   Unsubscribe
Accueil   À propos de nous   Nouvelles et Actualités   Contactez-nous   Version écrite   S'abonner   Se désabonner

Pharmaceutical Compounding
The business of pharmaceutical compounding is becoming increasingly regulated. New standards from the United States Pharmacopeial Convention (USP)'s Chapter 800 ("Hazardous Drugs–Handling in Healthcare Settings) take effect in 2019. First, the USP released Chapter 795, which provides guidelines for non-sterile compounding, followed by Chapter 797, which focused on sterile compounding. USP 800 goes further to regulate the handling of hazardous drugs in healthcare settings.  READ MORE

USP Compliance Opens Door to Pharmacy Redesign
Pharmacy Technology Report
The looming December 2019 deadline for compliance with the requirements of both U.S. Pharmacopeial Convention (USP) General Chapters <800> and <797> on the handling of hazardous drugs and sterile compounding is driving a wave of pharmacy redesign and expansion at hospitals and health systems across the country.  READ MORE

New Pharmacy Regulations
The United States Pharmacopeia (USP) <800> regulations are related to the safe handling of hazardous drugs.1These standards were developed to protect healthcare workers from hazardous drug exposure and to minimize the risks of these to public health by ensuring a quality healthcare environment.  READ MORE

Reducing & Safely Disposing of Hospital Waste
Facility managers can become easily overwhelmed when tasked with safely reducing facility waste. For starters, implementing sustainability initiatives can look incredibly different given the healthcare facility, the population it serves and the waste stream management protocol that may or may not already be in place.  READ MORE

Compounding Law Five Years Later
It has been five years since the passage of the Drug Quality and Security Act (DQSA) meant to address safety concerns about compounded drugs.1 The Food and Drug Administration (FDA) is still laboring to fulfill the law’s provisions, which were intended to allow the agency to walk the fine line between assuring public safety while ensuring access to legitimately and safely compounded drugs.  READ MORE

IsoTech Design eNews/Infolettre

IsoTech Design Inc.
1320 Graham Blvd, #120
Montreal, QC.
H3P 3C8

To unsubscribe, click here.
Pour vous désabonner, cliquez ici.

Did someone forward this edition to you?
Subscribe here -- it's free!

Est-ce que quelqu'un vous a transféré cette infolettre?
Abonnez-vous ici -- C'est gratuit!